[
    [
        {
            "time": "",
            "orginal_text": "3年大涨7倍！遭高瓴减持后，千亿医药巨头赴港IPO 减持股份",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "高瓴资本",
                    "减持",
                    "IPO"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "3年大涨7倍！遭高瓴减持后，千亿医药巨头赴港IPO 减持股份",
            "scores": {
                "News_content": "3年大涨7倍！遭高瓴减持后，千亿医药巨头赴港IPO 减持股份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "深耕肿瘤领域，恒瑞花13亿元引进新药",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "肿瘤",
                    "新药",
                    "引进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "深耕肿瘤领域，恒瑞花13亿元引进新药",
            "scores": {
                "News_content": "深耕肿瘤领域，恒瑞花13亿元引进新药",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "恒瑞医药引进基石药业全人源抗CTLA-4单克隆抗体",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "基石药业",
                    "CTLA-4",
                    "单克隆抗体"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒瑞医药引进基石药业全人源抗CTLA-4单克隆抗体",
            "scores": {
                "News_content": "恒瑞医药引进基石药业全人源抗CTLA-4单克隆抗体",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "2025年国内医药研发支出有望达496亿美元，创新环境迎来巨变",
            "features": {
                "keywords": [
                    "医药研发",
                    "创新环境",
                    "政策",
                    "支出"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "2025年国内医药研发支出有望达496亿美元，创新环境迎来巨变",
            "scores": {
                "News_content": "2025年国内医药研发支出有望达496亿美元，创新环境迎来巨变",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "港股异动 | 基石药业-B早盘高开逾11% 与恒瑞医药就CS1002达成在大中华地区的战略合作",
            "features": {
                "keywords": [
                    "基石药业",
                    "恒瑞医药",
                    "战略合作",
                    "CS1002"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "港股异动 | 基石药业-B早盘高开逾11% 与恒瑞医药就CS1002达成在大中华地区的战略合作",
            "scores": {
                "News_content": "港股异动 | 基石药业-B早盘高开逾11% 与恒瑞医药就CS1002达成在大中华地区的战略合作",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "A股融资融券日报：两融余额减少11.76亿元（11月19日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "A股融资融券日报：两融余额减少11.76亿元（11月19日）",
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少11.76亿元（11月19日）",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]